Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%)
< Home < Back

Zydus Lifesciences informs about investor presentation

Date: 25-11-2025
Zydus Lifesciences has informed that it enclosed a copy of the corporate presentation for records. In compliance with Regulation 46(2)(o)(ii) of the SEBI Listing Regulations, the said presentation is also uploaded on the website of the Company at www.zyduslife.com. 

The above information is a part of company’s filings submitted to BSE.